ACHAOGEN INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AKAOQ and buy or sell other stocks, ETFs, and their options commission-free!About AKAOQ
Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections. The company's most advanced drug candidate, ACHN-490, has demonstrated a positive safety and dosing profile in Phase 1 clinical testing and displayed broad spectrum efficacy in preclinical studies against systemic infections caused by multi-drug resistant (MDR) Gram-negative bacteria (e.g., E. coli, K. pneumoniae, and P. aeruginosa) and MRSA.
CEOBlake Wise, MBA
CEOBlake Wise, MBA
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2002
Founded2002
Employees—
Employees—
AKAOQ Key Statistics
Market cap1.60M
Market cap1.60M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume98.59K
Average volume98.59K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0469
52 Week high$0.0469
52 Week low$0.0003
52 Week low$0.0003
Stock Snapshot
As of today, ACHAOGEN INC Common Stock(AKAOQ) shares are valued at $0.03. The company's market cap stands at 1.6M.
On 2025-12-08, ACHAOGEN INC Common Stock(AKAOQ) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 98.59K.
Over the past 52 weeks, ACHAOGEN INC Common Stock(AKAOQ) stock has traded between a high of $0.05 and a low of $0.00.
Over the past 52 weeks, ACHAOGEN INC Common Stock(AKAOQ) stock has traded between a high of $0.05 and a low of $0.00.